T1	Condition 12 31	low ovarian reserve
T3	Measurement 66 69	AMH
T2	Value 70 81	= 1,5 ng/mL
T4	Measurement 89 103	basal CD 3 FSH
T5	Value 104 115	= 10 mIU/mL
T6	Measurement 123 143	basal CD 3 Estradiol
T7	Value 144 154	= 60 ng/mL
T8	Measurement 171 191	egg collection yield
T9	Value 192 203	= 3 oocytes
R1	Has_value Arg1:T3 Arg2:T2	
R2	Has_value Arg1:T4 Arg2:T5	
R3	Has_value Arg1:T6 Arg2:T7	
R4	Has_value Arg1:T8 Arg2:T9	
T10	Scope 66 203	AMH = 1,5 ng/mL and/or basal CD 3 FSH = 10 mIU/mL and/or basal CD 3 Estradiol = 60 ng/mL and/or previous egg collection yield = 3 oocytes
*	OR T3 T4 T6 T8
R5	Subsumes Arg1:T1 Arg2:T10	
T11	Condition 237 252	thyroid disease
T12	Condition 254 271	diabetes mellitus
T13	Condition 273 285	hypertension
T14	Condition 287 307	pulmonary conditions
T15	Condition 309 326	cardiac condition
*	OR T11 T12 T13 T14 T15
T16	Condition 338 361	male factor infertility
T17	Qualifier 331 337	Severe
R6	Has_qualifier Arg1:T16 Arg2:T17	
T18	Measurement 363 387	Total motile sperm count
T19	Value 388 402	< 5 million/ml
T20	Measurement 410 431	normal WHO morphology
T21	Value 432 436	<20%
R7	Has_value Arg1:T18 Arg2:T19	
R8	Has_value Arg1:T20 Arg2:T21	
*	OR T18 T20
T22	Scope 363 436	Total motile sperm count < 5 million/ml and/or normal WHO morphology <20%
R9	Subsumes Arg1:T16 Arg2:T22	
T23	Condition 440 456	Hypersensitivity
T24	Drug 460 467	Heparin
R10	AND Arg1:T23 Arg2:T24	
T25	Condition 498 511	thrombophilia
T26	Qualifier 489 497	Acquired
R11	Has_qualifier Arg1:T25 Arg2:T26	
T27	Condition 514 531	Active hemorrhage
T28	Observation 545 561	risk of bleeding
T29	Qualifier 535 544	increased
R12	Has_qualifier Arg1:T28 Arg2:T29	
T30	Condition 569 594	impairment of homeostasis
R13	AND Arg1:T28 Arg2:T30	
*	OR T27 T28
T31	Condition 604 623	impairment of liver
T32	Condition 604 617;627 646	impairment of pancreatic function
*	OR T31 T32
T33	Scope 604 646	impairment of liver or pancreatic function
T34	Qualifier 597 603	Severe
R14	Has_qualifier Arg1:T33 Arg2:T34	
T35	Qualifier 649 655	Severe
T36	Condition 656 675	renal insufficiency
R15	Has_qualifier Arg1:T36 Arg2:T35	
T37	Measurement 677 697	Creatinine Clearance
T38	Value 698 709	< 30 ml/min
R16	Has_value Arg1:T37 Arg2:T38	
R17	Subsumes Arg1:T36 Arg2:T37	
T39	Procedure 728 738	operations
T40	Condition 713 721	Injuries
T41	Qualifier 746 768	central nervous system
T42	Qualifier 770 774	eyes
T43	Qualifier 779 783	ears
T44	Temporal 795 808	last 2 months
*	OR T43 T42 T41
T45	Scope 746 783	central nervous system, eyes and ears
*	OR T39 T40
T46	Scope 713 738	Injuries to or operations
R18	Has_scope Arg1:T46 Arg2:T45	
R19	Has_temporal Arg1:T46 Arg2:T44	
T47	Condition 811 849	Disseminated Intravascular Coagulation
T48	Condition 851 854	DIC
R20	Subsumes Arg1:T47 Arg2:T48	
T49	Condition 872 904	heparin-induced thrombocytopenia
R21	AND Arg1:T47 Arg2:T49	
T50	Condition 940 958	endocarditis lenta
T51	Condition 907 935	Acute bacterial endocarditis
*	OR T50 T51
T52	Condition 965 979	organic lesion
T53	Observation 990 1006	risk of bleeding
T54	Qualifier 985 989	high
R22	Has_qualifier Arg1:T53 Arg2:T54	
R23	Has_context Arg1:T52 Arg2:T53	
T55	Condition 1014 1033	active peptic ulcer
T56	Condition 1035 1053	hemorrhagic stroke
T57	Condition 1055 1072	cerebral aneurysm
T58	Condition 1076 1094	cerebral neoplasms
*	OR T55 T56 T57 T58
T59	Scope 1014 1094	active peptic ulcer, hemorrhagic stroke, cerebral aneurysm or cerebral neoplasms
R24	Subsumes Arg1:T53 Arg2:T59	
